Lifeway Foods

Lifeway Foods, Inc. engages in the manufacture of probiotic and nutritious foods. Its products include kefir, organic kefir, plantiful, probugs, frozen kefir, cups and skyr, cheese, and supplements. The company distributes its products primarily through its direct sales force, brokers, and distributors. Lifeway Foods was founded by Michael Smolyansky and Ludmila Smolyansky in February 1986 and is headquartered in Morton Grove, IL.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

LWAY reports 11.2% net sales growth and improved profitability in Q1 2023

LWAY's Q1 2023 results demonstrate continued momentum from the record-breaking fiscal year 2022, with strong net sales growth and improved profitability. The company's focus on branded drinkable kefir and strategic investments in marketing and advertising programs position it well for future growth.

Lifeway Foods Reports Strong Q2 Earnings, Expands Distribution Opportunities

Lifeway Foods delivered strong financial results in Q2 2023, driven by increased sales and improved profitability. The company's focus on expanding distribution and investing in core products positions it well for future growth. However, managing expenses and capitalizing on the growing demand for Farmer Cheese will be key areas of focus.

Lifeway Foods Achieves Record Sales and Profitability, Eyes Product Expansion

Lifeway Foods' Q3 2023 performance reflects strong sales growth, improved profitability, and strategic investments in core products. The company's focus on consumer loyalty, marketing, and product expansion positions it well for future growth, although careful expense management and market adaptation will be essential.

Lifeway Foods reports record Q2 sales driven by kefir demand

Lifeway Foods' strong Q2 2024 performance reflects growth momentum, improved profitability, and strategic investments in expansion and product enhancement.
The company's focus on health trends, marketing initiatives, and distribution expansion positions Lifeway well for sustained growth and market competitiveness.
Challenges in product optimization, capital management, and market competition underscore the need for Lifeway to innovate and adapt to evolving consumer demands.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Study highlights the therapeutic benefits of the probiotics in kefir against oxidative stress and inflammation, which are important contributors to chronic neural disturbances including Parkinson's disease, Alzheimer's disease, dementia, and epilepsy Study highlights the therapeutic benefits of the probiotics in kefir against oxidative stress and inflammation, which are important contributors to chronic neural disturbances including Parkinson's disease, Alzheimer's disease, dementia, and epilepsy

Lifeway Foods Applauds New Research Examining the Potential for Probiotics in Kefir to Help Combat the Progression of Neurodegenerative Diseases

Delivers net sales of $29.6 million, an impressive 13.5% increase and the eighth consecutive quarter of year-over-year net sales growth

Lifeway Foods, Inc. Announces Results for the Third Quarter Ended September 30, 2021

Lifeway may be primed for strong business growth, underappreciated by Wall Street in October 2021. A conservative, liquid balance sheet and low valuation could support a long-term stock price advance into 2022-23.

The Bottom Fishing Club: Lifeway Foods

CEO of Leading Probiotic Kefir Company Recognized as Top Female Executive of the Year – Consumer Products CEO of Leading Probiotic Kefir Company Recognized as Top Female Executive of the Year – Consumer Products

Lifeway Foods CEO Julie Smolyansky Wins Gold Stevie® Award in 2021 Stevie Awards for Women in Business

Leading Kefir Brand Adds New, Vegan-Friendly Product Line to Its Probiotic Portfolio Leading Kefir Brand Adds New, Vegan-Friendly Product Line to Its Probiotic Portfolio

Lifeway Foods to Debut New Dairy-Free Probiotic Oat Beverage at Natural Products Expo East

Shares closing in on a firm bottom on the daily chart. Confidence should be boosted by the recently announced share buyback program.

3 Reasons Why Lifeway Foods Is About To Bottom

Lifeway's net sales have declined during 2017, 2018 and 2019. However, The coronavirus pandemic crisis increased both net sales and margins.

Lifeway Foods: There's Still A Lot Of Upside Potential

Acquires Certain Assets of California-Based Probiotic Drinkable Yogurt Brand to Capitalize on Demand for Local Brands in the West Acquires Certain Assets of California-Based Probiotic Drinkable Yogurt Brand to Capitalize on Demand for Local Brands in the West

Lifeway Foods Completes Acquisition of Certain GlenOaks Farms' Assets

Lifeway Foods Inc (NASDAQ: LWAY) reported second-quarter FY21 sales growth of 16.6% year-on-year, to $29.2 million primarily driven by higher volumes of its branded drinkable kefir. Gross profit rose 10.8% Y/Y to $7.7 million, and the gross margin declined 140 basis points Y/Y to 26.3% due to the unfavorable impact of milk pricing.

Lifeway Foods Records 16.6% Growth In Q2 Sales

Company delivers seventh consecutive quarter of year-over-year net sales increases Company delivers seventh consecutive quarter of year-over-year net sales increases

Lifeway Foods, Inc. Announces 16.6% Sales Increase for Second Quarter Ended June 30, 2021

Lifeway Kefir Now Available at Tesco Stores in Ireland Lifeway Kefir Now Available at Tesco Stores in Ireland

Lifeway Foods Announces Expanded Distribution in Ireland

Expands Position within the Better-for-You Drinkable Dairy Space Expands Position within the Better-for-You Drinkable Dairy Space

Lifeway Foods Announces Intent to Acquire Assets of GlenOaks Farms

Mango Lifeway Kefir Now Available at Costco in France Mango Lifeway Kefir Now Available at Costco in France

Lifeway Foods Announces Expansion into French Market

Lifeway Foods Inc (NASDAQ: LWAY) said its Board of Directors had approved a new share repurchase program of up to 250,000 shares. Lifeway will repurchase up to 250,000 shares of the company's common stock through the open market within two years from the program's effective date.

Lifeway Foods Stock Jumps On Authorizing 250K Share Buyback

MORTON GROVE, Ill., June 28, 2021 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. manufacturer of kefir and fermented probiotic products, announced today that Lifeway's Board of Directors has approved a new share repurchase program of up to 250,000 shares. Under such a program, Lifeway Foods may repurchase up to 250,000 shares of the Company's Common Stock through the open market within a period of two years from the effective date of the program. The Company will use its available cash resources generated through operations to fund the stock repurchase program.

Lifeway Foods Announces Share Repurchase Program

Delivers sixth consecutive quarter of year-over-year net sales increases and net income increase of nearly 800% Delivers sixth consecutive quarter of year-over-year net sales increases and net income increase of nearly 800%

Lifeway Foods, Inc. Announces Results for First Quarter Ended March 31, 2021

Study identifies molecules found in kefir as new drug candidates to combat pathogenic bacteria and treat various inflammatory conditions, including symptoms resulting from COVID-19 Study identifies molecules found in kefir as new drug candidates to combat pathogenic bacteria and treat various inflammatory conditions, including symptoms resulting from COVID-19

Lifeway Foods Commends New Research Further Positioning Kefir as a Potential Protective Dietary Supplementation Against Bacterial Infections

Lifeway Foods, Inc. (LWAY) CEO Julie Smolyansky on Q4 2020 Results - Earnings Call Transcript

Net Sales increase 8.9% Year-over-Year to $102 million Net Sales increase 8.9% Year-over-Year to $102 million

Lifeway Foods, Inc. Announces Fourth Quarter and Full Year Ended December 31, 2020

MORTON GROVE, Ill., March 18, 2021 (GLOBE NEWSWIRE) -- Lifeway Foods, Inc. (Nasdaq: LWAY) (“Lifeway” or “the Company”), the leading U.S. supplier of kefir and fermented probiotic products to support the microbiome, today announced it will report financial results for the fourth quarter and full year ended December 31, 2020 on Thursday, March 25, 2021 before market hours.

Lifeway Foods, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

Best-selling Kefir Brand Adds Two New Product Lines to Its Probiotic Portfolio Best-selling Kefir Brand Adds Two New Product Lines to Its Probiotic Portfolio

Lifeway Foods Introduces New 3.5oz Functional Shot Multipacks and Organic Whole Milk Grassfed Kefir

Aurora Cannabis

Antero Resources

Frontline

Nautilus

Patterson-UTI Energy

Tattooed Chef

Small-cap stocks can be value creators in 2021. Here are seven with strong fundamentals and positive industry tailwinds.

7 Small-Cap Stocks That Look Set for Robust Returns in the Coming Year

Chipotle

Sunopta

Before sitting down at the Thanksgiving table, focus on these stocks for healthy eating options, likely to gain traction in the coming year. The post 3 Food Stocks to Buy Before Sitting Down at the Thanksgiving Table appeared first on InvestorPlace.

3 Food Stocks to Buy Before Sitting Down at the Thanksgiving Table

Review suggests utilization of kefir as an inhibitor of expression of proinflammatory cytokines in COVID-19 could be viable policy Review suggests utilization of kefir as an inhibitor of expression of proinflammatory cytokines in COVID-19 could be viable policy

Lifeway Foods Applauds Recent Scientific Review Highlighting Kefir as a Potential Protective Dietary Supplementation Against Viral Infection

Third Quarter Net Sales Increase 14.6% Year-Over-Year to $26 Million Third Quarter Net Sales Increase 14.6% Year-Over-Year to $26 Million

News for Lifeway Foods Stock (LWAY)